SCHEMBL669993

SCHEMBL669993

CC/C=C\CC1C(O)CCC1CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
TBXA2R P21731 9/20 0.36
ALDH1A1 P00352 4/20 0.33
CYP19A1 P11511 2/20 0.33
RXRA P19793 2/20 0.33
PPARG P37231 2/20 0.33
OXER1 Q8TDS5 2/20 0.33
FFAR1 O14842 1/20 0.33
MAPT P10636 1/20 0.33
SLC6A12 P48065 3/20 0.32
SLC6A11 P48066 3/20 0.32
SLC6A13 Q9NSD5 3/20 0.32
F7 P08709 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
F3 P13726 1/20 0.31
PTGS1 P23219 1/20 0.31
KMT2A Q03164 1/20 0.31
PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30180824 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL6727796 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL669994 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853787 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853799 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL29517213 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL6727788 1.00 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL18853784 0.85 AKR1C4 (0.37) AKR1C4AKR1C3AKR1C2TBXA2RSLC6A12
SCHEMBL22814915 0.84 AKR1C4 (0.43) AKR1C4AKR1C3AKR1C2TBXA2RALDH1A1
SCHEMBL22814859 0.84 AKR1C4 (0.36) AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2223680-B1 Combination of monosaccharides and exfoliating agents and its cosmetic use L'ORÉAL (FR) 2017-10-18 EP claimed
EP-2448549-B1 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP L'ORÉAL (FR) 2017-10-11 EP claimed
EP-1333021-B1 COMPOSITIONS CONTAINING DERIVATIVES OF JASMONIC ACID AND THEIR USE FOR STIMULATING SKIN PEELING L'ORÉAL (FR) 2017-10-04 EP claimed
EP-3168206-A1 COMPOSITIONS COMPRISING DERIVATIVES OF JASMONIC ACID, AND USE OF SAID DERIVATIVES TO PROMOTE EXFOLIATION L'OREAL (FR) 2017-05-17 EP claimed
US-8679513-B2 Cosmetic use of a jasmonic acid derivative for treating the hair and the scalp L'OREAL (FR) 2014-03-25 US claimed
US-20120157527-A1 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP L'OREAL (FR) 2012-06-21 US claimed
EP-2448549-A2 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP L'Oréal (FR) 2012-05-09 EP claimed
US-20110152150-A1 CLEANSING COMPOSITION L'OREAL (FR) 2011-06-23 US claimed
WO-2011000903-A2 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP L'OREAL (FR) 2011-01-06 WO claimed
EP-2223680-A2 Combination of monosaccharides and exfoliating agents and its cosmetic use L'Oréal (FR) 2010-09-01 EP claimed
US-20100179222-A1 COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES L'OREAL S.A. 2010-07-15 US claimed
US-20100168041-A1 COMBINATION OF MONOSACCHARIDES AND DESQUAMATING AGENTS, AND USE THEREOF L'OREAL (FR) 2010-07-01 US claimed
US-20040029839-A1 Compositions comprising jasmonic acid derivatives and use of these derivatives L'OREAL S.A. (FR) 2004-02-12 US claimed
EP-1333021-A2 Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling L'OREAL (FR) 2003-08-06 EP claimed
US-12256733-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same L'OREAL (FR) 2025-03-25 US disclosed
US-12226509-B2 Cosmetic composition comprising a pasty fatty substance and a non-ionic derivative of hydrophobic-modified cellulose L'OREAL (FR) 2025-02-18 US disclosed
US-20230065230-A1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ACID OR SILVER-BASED COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2023-03-02 US disclosed
US-7250160-B2 Jasmonic acid and jasmonic acid ester stereoisomers and compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2007-07-31 US disclosed
US-20040029839-A1 Compositions comprising jasmonic acid derivatives and use of these derivatives L'OREAL S.A. (FR) 2004-02-12 US disclosed
EP-1333021-A2 Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling L'OREAL (FR) 2003-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029839-A1 Compositions comprising jasmonic acid derivatives and use of these derivatives CBR1, CBR3, DECR1 AKR1C4 66/4885AKR1C3 35/4885AKR1C2 91/4885
US-20100179222-A1 COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES CBR1, CBR3, DECR1 AKR1C4 56/4885AKR1C3 48/4885AKR1C2 122/4885
US-12226509-B2 Cosmetic composition comprising a pasty fatty substance and a non-ionic derivative of hydrophobic-modified cellulose NOTUM, FABP4, UGCG AKR1C4 3657/4885AKR1C3 3518/4885AKR1C2 3525/4885
US-20230065230-A1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ACID OR SILVER-BASED COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME KRT18, CUTA, EBP AKR1C4 1227/4885AKR1C3 900/4885AKR1C2 892/4885
US-20100168041-A1 COMBINATION OF MONOSACCHARIDES AND DESQUAMATING AGENTS, AND USE THEREOF MAN2A1, MANBA, DPM1 AKR1C4 3183/4885AKR1C3 3017/4885AKR1C2 2970/4885
US-20120157527-A1 COSMETIC USE OF A JASMONIC ACID DERIVATIVE FOR TREATING THE HAIR AND THE SCALP KRT18, ACOX3, PDIA3 AKR1C4 22/4885AKR1C3 6/4885AKR1C2 129/4885
US-12256733-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same KRT18, CUTA, EBP AKR1C4 1227/4885AKR1C3 900/4885AKR1C2 892/4885
US-20110152150-A1 CLEANSING COMPOSITION PHOSPHO1, DEGS1, SGMS1 AKR1C4 2809/4885AKR1C3 2378/4885AKR1C2 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.